A5003018832- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Kruppel-like factors research
- Renal function and acid-base balance
- Renal cell carcinoma treatment
- Galectins and Cancer Biology
- Potassium and Related Disorders
- Parathyroid Disorders and Treatments
- Systemic Sclerosis and Related Diseases
- Heart Failure Treatment and Management
- Extracellular vesicles in disease
- Advanced Nanomaterials in Catalysis
- Immune cells in cancer
- Cardiovascular Function and Risk Factors
- Electrolyte and hormonal disorders
Sun Yat-sen Memorial Hospital
2022-2024
Sun Yat-sen University
2022-2024
Xuzhou Medical College
2021
Background: IgA nephropathy (IgAN) is a cause of chronic kidney disease (CKD).Tubular atrophy/interstitial fibrosis associated with IgAN prognosis.However, simple tools for predicting pathological lesions remain limited.Our objective was to develop tool evaluating tubular in patients IgAN.Methods: In this cross-sectional study, 410 biopsy-verified were included.The factors the incident interstitial or atrophy confirmed by using logistic regression analysis.A nomogram developed coefficients...
Background IgA nephropathy (IgAN) is an immune disease related to oxidative stress and inflammation. It the most common type of glomerulonephritis in world cause chronic kidney end-stage renal (ESRD). The Geriatric Nutritional Risk Index (GNRI) a practical uncomplicated method assess risk morbidity mortality, but its ability IgAN still unclear. Here, we evaluated association between GNRI clinical histologic findings IgAN. Methods In cross–sectional study, included 348 biopsy-verified...
ABSTRACT Background Electrolyte abnormalities are common symptoms of chronic kidney disease (CKD), but previous studies have mainly focussed on serum potassium and sodium levels. Chloride is an important biomarker for the prognosis various diseases. However, relationship between chloride levels atrial fibrillation (AF) in CKD patients unclear. Objective In this study, we sought to determine association homeostasis AF patients. Methods retrospective cohort included who met diagnostic criteria...
Renin-angiotensin system inhibitors (RASi) are the first choice and basic therapy for treatment of IgA nephropathy (IgAN) with proteinuria. However, approximately 40% patients have no response to RASi treatment. The aim this study was screen potential biomarkers predicting in IgAN.We included IgAN who were treatment-naive. They received supportive treatment, including a maximum tolerant dose 3 months. According degree decrease proteinuria after months follow-up, these divided into sensitive...